Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.1B | 18.7B | 17.1B | 15.4B |
Cost of revenue | 4.1B | 3.9B | 3.5B | 3.3B |
Gross profit | 15.0B | 14.8B | 13.6B | 12.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.1B | 3.9B | 3.5B | 3.3B |
Other operating expenses | 2.7B | 2.9B | 2.7B | 2.3B |
Operating income | 4.1B | 4.0B | 3.7B | 3.1B |
Non operating interest income | ||||
Income | 276.9M | 233.1M | 352.9M | 309.5M |
Expense | 552.1M | 523.9M | 335.4M | 238.8M |
Other income expense | — | — | — | — |
Pretax income | 4.0B | 3.1B | 3.7B | 3.2B |
Tax provision | 835M | 700.7M | 918.8M | 850.4M |
Net income | 3.2B | 2.4B | 2.8B | 2.4B |
Basic EPS | — | 2.5 | 2.9 | 2.4 |
Diluted EPS | — | 2.4 | 2.9 | 2.4 |
Basic average shares | — | 970.7M | 971.8M | 972.3M |
Diluted average shares | — | 978.7M | 978.5M | 976.3M |
EBITDA | 5.6B | 5.3B | 4.9B | 4.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |